The FDA is expected to unpause the only protein-based COVID-19 vaccine's transition from emergency approval to full approval.

Novavax (NVAX) closed the most recent trading day at $6.41, making no change from the previous trading session. This change lagged the S&P 500's 1.47% gain on the day. At the same time, the Dow added ...

Robert F. Kennedy Jr. said in a July 2023 podcast interview that “there’s no vaccine that is, you know, safe and effective.” He told PBS NewsHour later that year that vaccines are the ...